- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Apple's $500 Check Worth $2.4 Million 50 Years Later - A Steve Jobs Signature Just Turned Into Gold | ||
| Fr | If Bitcoin Crashes To $55,000 This Year, These Two Crypto Stocks May Get Hammered | ||
| Fr | Expert Outlook: Norfolk Southern Through The Eyes Of 8 Analysts | ||
| Fr | Breaking Down ResMed: 7 Analysts Share Their Views | ||
| Fr | 4 Analysts Have This To Say About EPR Props | ||
| Fr | Analyst Expectations For GE HealthCare Techs' Future | ||
| Fr | Breaking Down Protagonist Therapeutics: 8 Analysts Share Their Views | ||
| Fr | A Look Into Barrick Mining Inc's Price Over Earnings | ||
| Fr | Forecasting The Future: 5 Analyst Projections For OSI Systems | ||
| Fr | Trump's Fed Chair Pick Triggers Gold, Silver's Worst Day Since 1980: What's Moving Markets Friday? | ||
| Fr | Nebius Shares Tumble As Tech Sell-Off Grips Market | ||
| Fr | Jamie Dimon Reportedly Blasted Brian Armstrong In Davos: 'You Are Full Of...' | ||
| Fr | Caterpillar Machinery Recovery Signals Next Growth Phase: Analyst | ||
| Fr | Bitcoin Down 8% In A Week And It Won't Get Much Better Till October, Analyst Warns | ||
| Fr | Snowflake Faces Rising Competition From Hyperscalers, Databricks | ||
| Fr | Alphabet Could Power Past Forecasts As AI Lifts Ads, Cloud: Analyst | ||
| Fr | Kyowa Kirin Regains Global Rights To Atopic Dermatitis Drug After Amgen Collaboration Ends | ||
| Fr | Analysts Maintain Bull Case On ResMed Despite Competition Concerns | ||
| Fr | New FDA-Approved Eye Drop Sparks Fresh Competition For LENZ Therapeutics' Drug | ||
| Fr | Where Sherwin-Williams Stands With Analysts | ||
| Fr | Cullen/Frost Bankers Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) | ||
| Fr | Breaking Down Celestica: 4 Analysts Share Their Views | ||
| Fr | 5 Analysts Have This To Say About Kosmos Energy | ||
| Fr | Breaking Down Modine Manufacturing: 4 Analysts Share Their Views | ||
| Fr | P/E Ratio Insights for Artisan Partners Asset |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.